rituximabhigh dose steroidsencephalitisplasma exchangeICUintravenous immunoglobulin
… dose steroids, intravenous immunoglobulin, plasma exchange and rituximab he has had a significant clinical improvement. However, his bil…
201articles mentioning drugs
354drug mentions
1distinct drugs extracted
0%of mentions human-reviewed
Active filtersEntity: rituximab ×
rituximab
This drug is selected. Its supporting articles are shown below.
Articles mentioning rituximab
201 articles · page 16 of 17Rituximab
…pairment which again responded to steroids and plasma exchange. Rituximab was added.This case expands the spectrum of movement disorder-p…
96.6%
HydroxychloroquinerituximabenoxaparinmethylprednisoloneSjogren’s syndromemetastatic endometrial cancerAPLStherapeutic anticoagulationpulmonary embolism
… post-thrombectomy, and methylprednisolone pulse was initiated. Hydroxychloroquine was re-commenced, and the patient received a four-week course o…
rituximabIVIGhigh-dose steroidsmononeuritis multiplextype 2 diabetes mellitusrheumatoid arthritisrheumatoid vasculitisRA
…ated and additional treatment with high-dose steroids, IVIG and rituximab were added. His progress has been slow, marked by the profound …
CyclophosphamideRituximabPLEXIVIgIVMPCCPDgastric cancerdiabetes insipidus
…uiring upescalation of therapies to include PLEX, Rituximab and Cyclophosphamide with significant morbidity.This case highlights the diagnostic …
ibrutinibrituximabhigh-dose intravenous methylprednisoloneDipeptidyl-peptidase-like protein-6 (DPPX) antibody-associated encephalitisImmunotherapychronic lymphocytic leukaemia (CLL)CLLB-cell neoplasmsanti-DPPX encephalitis
…months later his ACE-III score improved to 72/100. He commenced ibrutinib to prevent relapses of anti-DPPX encephalitis and CLL in future…
duloxetineGabapentintizanidinetocilizumabdiazepambaclofenmycophenolaterituximabcannabinoid oilsStiff person syndrome
…umab was used in one relapsing case with no effect. Gabapentin, duloxetine, diazepam, baclofen, tizanidine and cannabinoid oils were helpf…
natalizumabocrelizumabrituximabmultiple sclerosisMShigh-efficacy therapymonoclonal antibodies
… were identified in three MS registries. Patients who commenced natalizumab, ocrelizumab, or rituximab between ages 12–17 into the early tr…
azathioprinecyclophosphamiderituximaboral prednisonemyokymiaMPO-ANCA-associated vasculitisintravenous corticosteroids
…te rituximab, so was treated with cyclophosphamide, followed by azathioprine. Eight months later, MRI showed complete resolution of the lesi…
98.8%
rituximabbendamustinechronic lymphocytic leukaemiaend-stage renal diseaseBMJ Case Rep.CLLESRD
…Shoji J, Lew SQ. The use of rituximab and bendamustine in treating chronic lymphocytic leukaemia (CLL…
infliximabrituximabTacrolimusazathioprineMycophenolate mofetilallopurinolMMFAutoimmune hepatitis (AIH)liver failurecirrhosis+3 more
…ience supporting its long-term use. Among biological therapies, infliximab and rituximab have taken a leading role in the management of re…
rituximabRTXRTX-containingSLE-TTPSLElupusthrombotic thrombocytopenic purpuraRMTRTX-containing induction therapy
…s and treatment outcomes, as well as to explore the efficacy of rituximab (RTX) maintenance therapy (RMT) for relapse prevention and long…